Pressreleases

MPI Research Invests in an Additional Gyrolab™ xP Workstation

Gyros AB, a leader in utilization of microfluidic technologies to miniaturize and automate immunoassays, today announced that MPI Research has become the first contract research organization (CRO) in North America to secure a second Gyrolab™ xP workstation, a nanoliter-scale immunoassay platform.

Gyros AB Quality Management System Receives ISO 9001:2008 Certification

Gyros AB, a leader in utilization of microfluidic technologies to miniaturize and automate immunoassays, announced today its quality management system has received ISO 9001:2008 certification. The certification offers further reassurance to customers using the Gyros nanoliter-scale immunoassay platform that the products and services they receive are of a consistently high standard.

Gyros AB Appoints Dr Henrik Björkman as CTO and VP Technical Affairs

Gyros AB, a leader in utilization of microfluidic technologies to miniaturize and automate immunoassays, announced today that Dr Henrik Björkman has been appointed CTO and VP Technical Affairs, where he will lead the R&D and product supply teams.

Dec Group is further expanding its presence in the German market

The Dec Group with headquarters in Switzerland, is further expanding its presence in the German market and will as of 1st January, 2013 be operating a new sales office in Buchen, Germany.

QbD addressed at the VISION PHARMA in Karlsruhe

Manuel Zahn, Founder and Managing Director of 3R Pharma Consulting, agreed to present the topic "Quality by Design: Manufacturing at a comprehensive GMP level" at the VISION PHARMA in Karlsruhe, Germany, on 6 February 2013.

COPA-DATA introduces zenon 7.10

In March 2013, COPA-DATA will introduce a new version of its automation software. zenon 7.10 again focuses on the user and features pioneering technology, with its support of 64-bit, Windows 8 and Multi-Touch.

GVK BIO Enters into Research Collaboration with Endo Pharmaceuticals

GVK Biosciences (GVK BIO), Asia’s leading drug discovery research and development CRO announced today that it has entered into a collaboration agreement with U.S. based Endo Pharmaceuticals focused on discovering novel small molecules targeting an exciting protein.

Bioneer acquires Model Gut Contract Research business and is granted license to the Dynamic Gastric Model

Bioneer has signed an exclusive license agreement with UK technology management company, Plant Bioscience Limited (PBL), regarding use of the Dynamic Gastric Model (DGM) developed at the Institute of Food Research, UK. Bioneer has also acquired PBL's highly successful DGM contract research business, which provides specialist DGM services to the pharmaceutical and food-related industries. The Model Gut services will be integrated into Bioneer's own formulation services offered by Bioneer:FARMA.

Accelrys Strengthens Leadership Position in Laboratory Informatics Market

Accelrys Inc a leading provider of scientifi c innovation lifecycle management software, is solidifying its market leadership in the laboratory informatics space with the acquisition of its long-time partner Vialis AG, a leading systems integrator based in Liestal, Switzerland serving the pharmaceutical, biotechnology, chemicals, and agro-science industries.